For release at 6:30 a.m.

DUSA Pharmaceuticals, Inc.® to Host
Fourth Quarter and Full Year 2011 Corporate Highlights and
Financial Results Conference Call

Wilmington, Mass. - February 28, 2012 - DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its fourth quarter and full year 2011 corporate highlights and financial results press release will be issued on Tuesday, March 6th at 6:30 a.m. EST to be followed by a conference call and audio webcast at 8:30 a.m.  Conference call dial in and webcast log in details are as follows:

 Tuesday, March 6, 2012 - 8:30 a.m. EST
North American callers dial:
877-645-6210
International callers dial:
970-315-0447
Conference ID: 52287284

 To access the call online via webcast, please click here, or visit http://bit.ly/Af0mpG.

A telephone replay will be available shortly after the live call concludes. To access the replay, dial 855-859-2056 (North American callers) or 404-537-3406 (International callers). The telephone replay and webcast will also be accessible on the investors section of our website approximately six hours following the call at www.dusapharma.com.

About DUSA Pharmaceuticals

DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan® PDT technology platform.  Levulan® Kerastick® for topical solution plus DUSA's BLU-U® Blue Light Photodynamic Therapy Illuminator is currently approved for the treatment of minimally to moderately thick actinic keratoses (AKs) of the face or scalp.  DUSA is based in Wilmington, Mass.  Please visit our website at www.dusapharma.com.

For further information contact:
Chad Rubin, The Trout Group LLC
Tel: 646-378-2947